Abstract
The report covers a forecast and an analysis of the plasma fractionation market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the plasma fractionation market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the plasma fractionation market on a global and regional level.
In order to give the users of this report a comprehensive view of the plasma fractionation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the plasma fractionation market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the plasma fractionation market on a global and regional basis.
The study provides a decisive view of the plasma fractionation market by segmenting it based on product, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players operating in the global plasma fractionation market are Green Cross, Biotest, Octapharma, LFB, Japan Blood Products, China Biologic Products, CSL, Shanghai RAAS Blood, Kedrion, and BPL.
This report segments the global plasma fractionation market into:
Plasma Fractionation Market: By Product
Protease Inhibitors
Albumin
Coagulation Factor Concentrates
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrate
Factor XIII
Fibrinogen Concentrates
Immunoglobulins
Intravenous Immunoglobulins
Subcutaneous Immunoglobulins
Other Immunoglobulins
Others
Plasma Fractionation Market: By Application
Immunology
Hematology
Neurology
Rheumatology
Pulmonology
Others
Plasma Fractionation Market: By End-User
Hospitals and Clinics
Clinical Research Laboratories
Medical and Academic Institutes
Others
Global Plasma Fractionation Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa